Clinical trials for medicines: Inclusion and Diversity Plan pilot findings published
Safety Classified by Officially
During the pilot, which ran for 6 months in 2025, the Medicines and Healthcare products Regulatory Agency’s (MHRA) and the HRA’s draft guidance on developing a plan was tested by a small group of commercial and non-commercial researchers and sponsors.
The group submitted a Plan alongside their application for a Research Ethics Committee (REC) review.
The Plan helps researchers consider and demonstrate how they plan to enrol the full range of people who will use the drugs, devices or intervention they are testing.
The Plan also helps RECs to understand decisions researchers have made about who to recruit into their trials, to support discussions at the research ethics review meeting.
The development of the guidance was part of the MHRA and HRA’s work to update the UK’s clinical trial regulations.
The guidance and its implementation also feeds into the wider cross-sector work of the UK Clinical Research Inclusion Group, to support greater access to, and inclusion in, clinical research.
Seven studies took part in the pilot, including studies from commercial and non-commercial sponsors. Five of the studies were phase 3 Clinical Trials of Investigational Medicinal Products and two were for medical devices.
Overall, the findings from the pilot indicate that:
The latest version of the guidance has now been updated in response to the pilot findings.
From early 2027 we will be asking more researchers and sponsors to volunteer to submit a Plan alongside their applications.
Feedback will be collected over a 12 month period where we will gather further evidence on the benefits of developing a Plan.
This is an extract. The publication continues at the source.
Contains public sector information licensed under the Open Government Licence v3.0. Licence
Read the original at the source: https://www.gov.uk/government/news/clinical-trials-for-medicines-inclusion-and-diversity-plan-pilot-findings-published
Officially imported this from Medicines and Healthcare products Regulatory Agency’s own source and shows an extract. If you work there, claiming the profile and verifying the domain lets you choose to show the full text here.
Provenance
- Organization
- Medicines and Healthcare products Regulatory Agency — imported from official source
- Official source
- https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency.atom ATOM
- Imported
- November 03, 2026 10:00
- Versions
- 1 recorded
- Identity
-
https://www.gov.uk/government/news/clinical-trials-for-medicines-inclusion-and-diversit...